Health Care: Drugs

Discovery Laboratories Inc (DSCO: NASDAQ)

$1.98 0.06 | 3.12%
04/22/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 388.00K 195.00K 582.00K 0.00
Cost of Sales 517.00K 0.00 0.00 0.00
Gross Operating Profit -129.00K 195.00K 582.00K 0.00
Selling, General, and Administrative Expenses 16.72M 16.44M 7.86M 8.39M
Research & Development 27.66M 21.57M 17.23M 17.14M
Operating Income before D & A (EBITDA) -44.51M -37.82M -24.51M -25.53M
Depreciation & Amortization 1.24M 1.15M 1.23M 1.55M
Interest Income 3.00K 6.00K 13.00K 288.00K
Other Income - Net 761.00K 555.00K 3.56M 6.42M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -44.98M -38.41M -22.17M -20.37M
Interest Expense 1.47M 57.00K 26.00K 357.00K
Pre-Tax Income -46.46M -38.46M -22.20M -20.72M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -45.22M -37.32M -20.96M -19.18M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -45.22M -37.32M -20.96M -19.18M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -45.22M -37.32M -20.96M -19.18M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-45.22M -37.32M -20.96M -19.18M
Preferred Dividends
Net Income Available To Common -45.22M -37.32M -20.96M -19.18M
Basic EPS from Continuing Ops. -0.82 -0.95 -0.93 -1.65
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.82 -0.95 -0.93 -1.65
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.82 -0.95 -0.93 -1.65
Basic Normalized Net Income/Share -0.82 -0.95 -0.93 -1.65
EPS fr Continuing Ops. -0.82 -0.95 -0.93 -1.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.82 -0.95 -0.93 -1.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.82 -0.95 -0.93 -1.65
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.82 -0.95 -0.93 -1.65
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DSCO

Latest DSCO Headlines from TheStreet

More Financial News for DSCO

Press Releases for DSCO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter